ChemWerth Executives attend GPhA Annual Meeting, 2010

ChemWerth founder and CEO Peter J. Werth together with Chief Strategy Officer David Moore and VP of Sales Ed Vanderbeck attended GPhA Meeting in Naples, Florida.

Chemwerth supports GPhA in their role as the Generic Pharmaceutical’s conduit into Washington and throughout the United States.  As always, the discussions by the industry leaders, FDA and Washington were informative and allowed for an in depth view of the Generic Pharmaceutical industry.  The venue also allowed for valuable networking time and the opportunity to strengthen existing relationships as well as establish new relationships.

About ChemWerth

Established in 1982, ChemWerth is a full service generic drug development and supply company providing high quality Active Pharmaceutical Ingredients to regulated markets worldwide.

Through exclusive development and partnerships with API manufacturers, ChemWerth provides expertise in product selection & development; analytical and regulatory services and strong project management to ensure the highest standards of quality.

<< Return to ChemWerth News